Skip to content

4502.T

Takeda Pharmaceutical Company Limited

プライム · 医薬品 · 医薬品 · JP

JPY 5,946.00
+1.69%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue4618.9B4505.7B4581.6B4263.8B4027.5B
Cost of Revenue406.7B1571.6B1580.2B1426.7B1244.1B
Gross Profit813.2B2934.1B3001.3B2837.1B2783.4B
Operating Expenses
R&D Expense167.4B
SG&A Expense286.5B1084.2B1104.8B1053.8B997.3B
General & Admin Expense
Selling & Marketing Expense
Other Expenses157.9B
Total Operating Expenses611.8B1084.2B1104.8B1053.8B997.3B
Cost and Expenses4193.3B4499.5B4239.0B4049.7B3537.0B
Operating Income (EBIT)425.6B6.2B342.6B214.1B490.5B
Non-Operating
Interest Income24.6B211.2B46.5B52.1B62.9B
Interest Expense63.8B357.6B210.1B219.8B169.7B
Net Interest Income(39.2B)(146.4B)(163.5B)(167.8B)(106.8B)
Other Non-Op Income/Expense(38.7B)
Non-Operating Income (excl Interest)(25.1B)
EBT (Pre-Tax Income)162.7B(142.4B)175.1B52.8B375.1B
Income Tax Expense49.5B9.8B66.9B(91.4B)58.1B
Bottom Line
Net Income180.7B(152.4B)107.9B144.1B317.0B
Earnings from Cont. Ops113.3B
Earnings from Discont. Ops
Bottom Line Net Income180.9B(152.1B)108.1B144.2B317.0B
Per Share
Basic EPS¥79(¥97)¥68¥92¥204
Diluted EPS¥78(¥97)¥67¥91¥202
Revenue Per Share¥1,462¥2,861¥2,902¥2,725¥2,595
Shares
Basic Shares Outstanding3.2B1.6B1.6B1.6B1.6B
Diluted Shares Outstanding3.2B
Profitability Metrics
EBITDA337.5B727.3B1104.0B942.1B1154.9B
D&A110.9B721.1B761.4B728.0B664.4B
EBIT450.8B6.2B342.6B214.1B490.5B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026